Li, W.; Arasu, V.; Newitt, D.C.; Jones, E.F.; Wilmes, L.; Gibbs, J.; Kornak, J.; Joe, B.N.; Esserman, L.J.; Hylton, N.M., ACRIN 6657 Trial Team and I-SPY Investigators Network. Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL. Tomography 2016, 2, 378-387. https://doi.org/10.18383/j.tom.2016.00247

AMA Style

Li W, Arasu V, Newitt DC, Jones EF, Wilmes L, Gibbs J, Kornak J, Joe BN, Esserman LJ, Hylton NM ACRIN 6657 Trial Team and I-SPY Investigators Network. Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL. Tomography. 2016; 2(4):378-387. https://doi.org/10.18383/j.tom.2016.00247

Chicago/Turabian Style

Li, Wen, Vignesh Arasu, David C. Newitt, Ella F. Jones, Lisa Wilmes, Jessica Gibbs, John Kornak, Bonnie N. Joe, Laura J. Esserman, and Nola M. Hylton ACRIN 6657 Trial Team and I-SPY Investigators Network. 2016. "Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL" Tomography 2, no. 4: 378-387. https://doi.org/10.18383/j.tom.2016.00247

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI